课题基金 / 基金详情

Clinical importance of aberrant splicing of pre-mRNA encoding a glycolytic enzyme in colorectal cancer and its potential for diagnostic marker

Clinical importance of aberrant splicing of pre-mRNA encoding a glycolytic enzyme in colorectal cancer and its potential for diagnostic marker
编码糖酵解酶的前 mRNA 异常剪接在结直肠癌中的临床重要性及其作为诊断标记物的潜力
批准号:
22659248
负责人:
SHIIBA Kenichi
金额:
$2.09万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Challenging Exploratory Research
财政年份:
2010
资助国家:
日本
项目状态:
已结题
起止时间:
2010 至 2011

项目摘要

项目成果

SHIIBA Kenichi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Analysis using clinical speicmens revealed an aberrant pre-mRNA splicing of pyruvate kinase M(PKM) in early phase during colon carcinogenesis. Such splicing dys-regulation was also observed in aberrant crypt foci of animal models. In addition, we found up-regulation of genes encoding several splicing factors, probably eliciting aberrant PKM splicing in colorectal tumor. Knock-down of these splicing factors partially restored PKM splicing-regulation of cell-lines.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间: 2011-03
期刊: Hepato-gastroenterology
影响因子: --
作者: [M. Kinouchi;K. Miura;T. Mizoi;K. Ishida;W. Fujibuchi;T. Ando;Nobuki Yazaki;Kazuya Saito;Ken‐ichi Shiiba;I. Sasaki]
通讯作者: M. Kinouchi;K. Miura;T. Mizoi;K. Ishida;W. Fujibuchi;T. Ando;Nobuki Yazaki;Kazuya Saito;Ken‐ichi Shiiba;I. Sasaki
Conversion of pyruvate kinase M (PKM) isozymes in human cancers - an analysis using isoform-specific antibodies
人类癌症中丙酮酸激酶 M (PKM) 同工酶的转化 - 使用同工型特异性抗体进行分析
DOI: --
发表时间: 2010
期刊:
影响因子: --
作者: [野村美有樹, 田沼延公, 佐々木希, 島礼]
通讯作者: 島礼
退形性膵管癌(紡錘細胞型)の1例
间变性胰腺导管癌(梭形细胞型)1例
DOI: --
发表时间: 2012
期刊: 日本臨床外科学会誌
影响因子: --
作者: [菊川利奈, 佐藤正幸, 山並秀章, 藤谷恒明, 伊藤しげみ, 佐藤郁郎, 椎葉健一]
通讯作者: 椎葉健一
DOI: 10.1093/nar/gkq643
发表时间: 2010-11
期刊: Nucleic acids research
影响因子: 14.9
作者: [Van Dessel N, Beke L, Görnemann J, Minnebo N, Beullens M, Tanuma N, Shima H, Van Eynde A, Bollen M]
通讯作者: Bollen M
17
    A study of novel transporters resposible for Uptake of the anticancer drugs a new strategy to increase the efficacy of anticancer drugs
    • 批准号:
      13470231
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.37万
    • 财政年份:
      2001
    • 负责人:
      SHIIBA Kenichi
    • 依托单位:
    海外基金